This page is a redirect. The following categories are used to track and monitor this redirect:
With possibilities: This is a redirect from a title that potentially could be expanded into a new article or other type of associated page such as a new template. The topic described by this title may be more detailed than is currently provided on the target page or in a section of that page.
When the target page becomes too large, or for any reason a new page would be an improvement, this redirect may be replaced with an article, template or other project page that is carved out of the target page. See also {{R to section}} and use together with this rcat when appropriate.
If the topic of the redirect is not susceptible to expansion, then use other rcats such as {{R to section}} or {{R to list entry}}when appropriate.
Since a new page may be created, links to this redirect should not be replaced with a direct link to the target page. To make redirects to this page, use {{R avoided double redirect}}.
{{R printworthy}} should be used together with this template when applied to a redirect in mainspace.
From an alternative name: This is a redirect from a title that is another name or identity such as an alter ego, a nickname, or a synonym of the target, or of a name associated with the target.
This redirect leads to the title in accordance with the naming conventions for common names to aid searches and writing. It is not necessary to replace these redirected links with a piped link.
If this redirect is an incorrect name for the target, then {{R from incorrect name}} should be used instead.
When appropriate, protection levels are automatically sensed, described and categorized.
Informasi yang berkaitan dengan en/Alogliptin/pioglitazone